Geron reported $716.3M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 189.89B 13.64B Mar/2026
Bio Techne USD 8.18B 987M Mar/2026
Cassava Sciences USD 96M 45M Dec/2025
Cytokinetics USD 8.19B 420M Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Exelixis USD 10.89B 857M Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Geron USD 955M 112M Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
Incyte USD 18.73B 660M Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Novavax USD 1.09B 316M Dec/2025